TITLE

Molecular genetics and palliative medicine: What is the link?

AUTHOR(S)
Fallon, Marie
PUB. DATE
July 2000
SOURCE
Palliative Medicine;Jul2000, Vol. 14 Issue 4, p255
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Studies the palliative effects of opioid drugs on animal models. Analgesic and sedative effects of morphine; Various opioid receptors in mice; Production of transgenic mice with deficiency in endogenous genes; Advantages of the knockout approach in the opioid system; Limitations of the opioid knockout mice.
ACCESSION #
3482643

 

Related Articles

  • Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the... Matthes, Hans W.D.; Maldonado, Rafael // Nature;10/31/1996, Vol. 383 Issue 6603, p819 

    Presents a study which disrupts the mu-opioid-receptor gene in mice by homologous recombination. The finding that there are no overt behavioral abnormalities or major compensatory changes within the opioid system; Investigation of the behavioral effects of morphine; The conclusion that the...

  • Mu-Opioid Receptor Coupling to Gαo Plays an Important Role in Opioid Antinociception. Lamberts, Jennifer T.; Jutkiewicz, Emily M.; Mortensen, Richard M.; Traynor, John R. // Neuropsychopharmacology;Sep2011, Vol. 36 Issue 10, p2041 

    Opioid analgesics elicit their effects via activation of the mu-opioid receptor (MOR), a G protein-coupled receptor known to interact with Gαi/o-type G proteins. Work in vitro has suggested that MOR couples preferentially to the abundant brain Gαi/o isoform, Gαo. However, studies in...

  • Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. Nguyen, J.; Luk, K.; Vang, D.; Soto, W.; Vincent, L.; Robiner, S.; Saavedra, R.; Li, Y.; Gupta, P.; Gupta, K. // BJA: The British Journal of Anaesthesia;Jul2014 Supplement 1, Vol. 113, pi4 

    Background Morphine stimulates angiogenesis and cancer progression in mice. We investigated whether morphine influences tumour onset, development, and animal model survival, and whether µ-opioid receptor (MOR), lymphangiogenesis, mast cell activation, and substance P (SP) are associated with...

  • [Dmt�]DALDA is Highly Selective and Potent at � Opioid Receptors, but is not Cross-Tolerant with Systemic Morphine. Riba, Pal; Yong Ben, Pal; Nguyen, Thi M.-D.; Furst, Susanna; Schiller, Peter W.; Lee, Nancy M. // Current Medicinal Chemistry;Jan2002, Vol. 9 Issue 1, p31 

    The clinical effectiveness of morphine is limited by several side effects, including the development of tolerance and dependence. Most of these side effects are believed to be mediated by central opioid receptors therefore, hydrophilic opioids, which don't cross the blood-brain barrier, may have...

  • Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers. Lötsch, J.; Geisslinger, G. // Pharmacogenomics Journal;2006, Vol. 6 Issue 3, p200 

    Polymorphisms in the μ-opioid receptor gene (OPRM1) are primary candidate sources of clinical variability in opioid therapy. Apart from the 118A>G single nucleotide polymorphism, nothing is known about the role of OPRM1 mutations in opioid therapy. The influence of the OPRM1 mutations on...

  • Transgenic Mouse Studies Reveal Substantial Roles for Opioid Receptors in the Rewarding Effects of Several Classes of Addictive Drugs. Hall, F. Scott; Uhl, George R. // Current Psychiatry Reviews;2006, Vol. 2 Issue 1, p27 

    In recent years transgenic studies in mice, in particular those utilizing gene knockout techniques, have greatly contributed to our understanding of the molecular mechanisms of drug reward and drug abuse. Many of the initial gene knockouts that have been created focused on the initial molecular...

  • Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Dykstra, A.; Granger, Arthur L.; Allen, Richard M.; Zhang, Xiaoyan; Rice, Kenner C. // Psychopharmacology;2002, Vol. 163 Issue 3/4, p420 

    Rationale: The nonpeptidic compound SNC80 [(+)-4[(αR)-α-((2S, 5R)-4-allyl-2, 5,-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide], has a high degree of selectivity for delta opioid receptors. Moreover, compounds with delta opioid activity have been shown to enhance the effects...

  • The Opiate Receptor. Snyder, Solomon H.; Pert, Candace B.; Pasternak, Gabril W. // Annals of Internal Medicine;Oct74, Vol. 81 Issue 4, p534 

    Deals with a study which demonstrated the binding of radioactive opiates and opiate antagonists to the opiate receptor in the brain and other tissues. Biochemical identification of opiate receptor binding; Regional distribution of the receptor; Subcellular localization.

  • RSK2 Signaling in Medial Habenula Contributes to Acute Morphine Analgesia. Darcq, Emmanuel; Befort, Katia; Koebel, Pascale; Pannetier, Solange; Mahoney, Megan K; Gaveriaux-Ruff, Claire; Hanauer, André; Kieffer, Brigitte L // Neuropsychopharmacology;Apr2012, Vol. 37 Issue 5, p1288 

    It has been established that mu opioid receptors activate the ERK1/2 signaling cascade both in vitro and in vivo. The Ser/Thr kinase RSK2 is a direct downstream effector of ERK1/2 and has a role in cellular signaling, cell survival growth, and differentiation; however, its role in biological...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics